13 articles for A Di Pietro
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
15
New, highly potent and non-toxic, chromone inhibitors of the human breast cancer resistance protein ABCG2.
University of Lyon 1
18
Converting potent indeno[1,2-b]indole inhibitors of protein kinase CK2 into selective inhibitors of the breast cancer resistance protein ABCG2.
Bmssi Umr 5086 Cnrs/Universit£
16
Symmetric bis-chalcones as a new type of breast cancer resistance protein inhibitors with a mechanism different from that of chromones.
Bmssi Umr 5086 Cnrs/Universit£
6
Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity.
Bmssi Umr 5086 Cnrs/Universit£
7
Substituted chromones as highly potent nontoxic inhibitors, specific for the breast cancer resistance protein.
Cnrs/Universit£
14
Acridone derivatives: design, synthesis, and inhibition of breast cancer resistance protein ABCG2.
Umr 5063 Cnrs/Universit£
2
Nonprenylated rotenoids, a new class of potent breast cancer resistance protein inhibitors.
Umr 5086 Cnrs/Universit£
10
The flavanolignan silybin and its hemisynthetic derivatives, a novel series of potential modulators of P-glycoprotein.
University of Lyon 1
6
Potent and fully noncompetitive peptidomimetic inhibitor of multidrug resistance P-glycoprotein.
Umr 5086 Cnrs
2
(R)- and (S)-verapamil differentially modulate the multidrug-resistant protein MRP1.
Institut De Biologie Et Chimie Des ProtéInes
20
Uncompetitive nanomolar dimeric indenoindole inhibitors of the human breast cancer resistance pump ABCG2.
Claude Bernard University Lyon 1
8
B-ring substituted 5,7-dihydroxyflavonols with high-affinity binding to P-glycoprotein responsible for cell multidrug resistance.
DéPartement De Pharmacochimie MoléCulaire Umr-Cnrs 5063